Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Article
Improving Outcomes in the Face of Natural Disasters
Workers' Comp
News Release
Press Release - Coventry Receives URAC Re-Accreditation for Case Management
Mitchell
News Release
Mitchell Announces Strategic Agreement with Assured Performance Network for Audit & Inspection Services
Assured Performance named as an Audit & Inspection Vendor for Mitchell's Collision Repair Network Management solutions
Workers' Comp
Article
StateWatch: Bill Review August / September 2018
Keep current with new legislation and its potential effect on your organization.
Mitchell
News Release
General Motors and Mitchell Launch GM Collision Repair Network Enrollment Portal at NACE Automechanika Atlanta
Mitchell, exclusive GM Collision Repair Network administrator, will oversee enrollments, ensure participants meet high standards for facili
Mitchell
Article
Artificial Intelligence: Ready to Simplify the Auto Claims Workflow
The P&C industry has been buzzing for a while about the emergence of “smart” technology entering the claims workflow—from natural language proc